SEC
SlamSEC
SearchBrowseEarnings

BridgeBio Pharma, Inc.

Nasdaq:BBIO
Pharmaceutical Preparations·PALO ALTO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(749 total)

TypeDateAccessionPeriodSize
4
Mar 12, 2026
0001470831-26-000260FORM 4
Mar 10, 2026
8.9 KB
144
Mar 10, 2026
0001950047-26-002400
—
5.5 KB
4
Mar 6, 2026
0001470831-26-000252FORM 4
Mar 4, 2026
8.6 KB
144
Mar 4, 2026
0001950047-26-002147
—
4.8 KB
4
Mar 3, 2026
0001470831-26-000236FORM 4
Feb 27, 2026
11.0 KB
144
Feb 27, 2026
0001950047-26-001893
—
4.8 KB
4
Feb 27, 2026
0001470831-26-000225FORM 4
Feb 26, 2026
4.7 KB
10-K
Feb 24, 2026
0001743881-26-00000910-K
Dec 31, 2025
17.3 MB
8-K
Feb 24, 2026
0001743881-26-0000088-K
Feb 24, 2026
439.0 KB
4
Feb 23, 2026
0001470831-26-000214FORM 4
Feb 19, 2026
10.6 KB
144
Feb 19, 2026
0001950047-26-001512
—
14.9 KB
4
Feb 18, 2026
0001470831-26-000188FORM 4
Feb 16, 2026
17.7 KB
4
Feb 18, 2026
0001470831-26-000186FORM 4
Feb 16, 2026
6.6 KB
4
Feb 18, 2026
0001470831-26-000184FORM 4
Feb 16, 2026
8.1 KB
4
Feb 18, 2026
0001470831-26-000182FORM 4
Feb 17, 2026
13.1 KB
SCHEDULE 13D/A
Feb 17, 2026
0000905148-26-000914
—
58.0 KB
144
Feb 17, 2026
0001950047-26-001375
—
5.0 KB
144
Feb 17, 2026
0001950047-26-001308
—
4.8 KB
SCHEDULE 13G
Feb 17, 2026
0001274173-26-000074
—
11.7 KB
4
Feb 12, 2026
0001470831-26-000118FORM 4
Feb 10, 2026
28.2 KB
8-K
Feb 12, 2026
0001140361-26-0049958-K
Feb 12, 2026
197.1 KB
8-K
Jan 21, 2026
0001140361-26-0018438-K
Jan 14, 2026
2.8 MB
4
Jan 12, 2026
0001470831-26-000026FORM 4
Jan 8, 2026
32.2 KB
8-K
Jan 12, 2026
0001140361-26-0009718-K
Jan 12, 2026
8.1 MB
144
Jan 8, 2026
0001950047-26-000276
—
13.5 KB
25 filings shown
CEO
Kumar Neil
CFO
Trimarchi Thomas